Ann: Change in substantial holding - D.Williams, page-12

First 12 Last

Share
Profile

Follow
Luckyphil1

1,460 Posts.

281

31/03/22

18:30

Post #: 60559020
Share

Originally posted by Hasaman: ↑

I think you're way off on the idea of DW taking RMY private.

Firstly he has a loyal following of investors who have supported his numerous ventures, MVP, PNV as examples. This shows by the small number of investors in RMY as well as the small average volume of RMY shares that are generally traded on the open market at a daily level.

Secondly he has the personal liquidity to soak up the current few nervous sellers reacting right or wrongly to the current investment environment. He is a great asset for all RMY shareholders ATM by providing a floor for the share price through block trades or on market purchases.

And last but not least, if you have ever listened to any of his Chairman announcements you will know he is for the shareholder first and foremost and gets great satisfaction from creating personal wealth for his band of loyal followers.

RMY is at the cusp of profitability and this will be reflected in the share price soon enough even with all the global events unfolding in front of all of us.

Realestate will always be bought and sold for a given price regardless of global influences and agents need to promote themselves to gain an advantage over their competitors and the RMY platform supports their needs.

And we are not even talking about the $ value of the data that the platform garnishes off the web and it’s value that can be leverage to big “Big Data” company’s for added financial gain on top off the subscription model potential.

Look at the background of the two brothers whom are both recent RMY company director appointments to see the potential direction that this data load can be directed towards?

Data is power and companies pay for this information, oh and RMY is a SAAS subscription model to boot!

Whats not to like but the current SP, but not for long IMHO.

Hasaman.

Expand

im still accumulating also and usually pick up at same price as dw

RMY Price at posting: 19.0¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 1 more message in this thread...

First 12 Last

Add RMY (ASX) to my watchlist

(20min delay)
Last 6.0¢		Change 0.002(3.45%)		Mkt cap ! $32.91M

Open	High	Low	Value	Volume
5.9¢	6.0¢	5.9¢	$4.138K	69.49K

Buyers (Bids)

No.	Vol.	Price($)
3	212322	5.6¢

Sellers (Offers)

Price($)	Vol.	No.
5.9¢	16085	1

View Market Depth

No.	Vol.	Price($)
3	212322	0.056
1	999999	0.055
1	18867	0.053
1	9803	0.051
3	37865	0.050

Price($)	Vol.	No.
0.059	16085	1
0.060	386363	1
0.062	99343	1
0.065	125162	1
0.070	185176	2

Last trade - 11.42am 04/10/2024 (20 minute delay)

RMY (ASX) Chart

Ann: Change in substantial holding - D.Williams, page-12

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Change in substantial holding - D.Williams, page-12

Top Stories

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News